Xeris Pharmaceuticals INC
SEC CIK 1346302 · XERS · last insider filing 2021-10-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sherman Jeffrey W | Director | filed 2018 - 2021 |
| Persky Marla | Director | filed 2018 - 2021 |
| Schmid John P. | Director | filed 2018 - 2021 |
| Edick Paul R | Director · See Remarks | filed 2018 - 2021 |
| Bormann-Kennedy Barbara-Jean Anne | Director | filed 2018 - 2021 |
| Halkuff Dawn | Director | filed 2018 - 2021 |
| Thierer Mark | Director | filed 2019 - 2020 |
| Rigby Jonathan | Director | filed 2018 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shannon John Patrick Jr | See Remarks | filed 2018 - 2021 |
| Hecht Beth | See Remarks | filed 2019 - 2021 |
| Johnson Kenneth Erland | See Remarks | filed 2018 - 2021 |
| Prestrelski Steven | See Remarks | filed 2018 - 2021 |
| Pieper Steven | See Remarks | filed 2021 - 2021 |
| Deutsch Barry M. | See Remarks | filed 2018 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.